Abstract
The estrogen receptor (ER) is a member of a large family of transcription factors including steroid/thyroid hormone receptors (Evans 1988). These receptors share a conserved structural and functional organization, which includes separable domains for hormone binding (HBD), DNA binding, and transcriptional activation (Tsai and O’Malley 1994). Like other members of the nuclear hormone receptor superfamily, ER has at least two transcriptional activation functions (AFs), one in its amino-terminal region (AF-1) and the second in its carboxy-terminal, ligand-binding region (AF-2) (Kumar et al. 1987; Webster et al. 1988). According to the classical model of steroid hormone action, hormone enters cells by passive diffusion where it binds to and induces a conformational change in its cognate receptor protein. This leads to the release of the inhibitory heat shock protein 90 complex, nuclear translocation, interaction with chromatin, and modulation of gene expression. Steroid receptors can activate transcription of genes containing in their 5’ flanking region a specific DNA sequence called the hormone response element (HRE; ERE for ER). Before and upon ligand binding, ER is phosphorylated at several sites (Ali et al. 1993; Le Goff et al. 1994). The importance of phosphorylation in modulating transcriptional functions of ER, as well as of other steroid receptors, has been highlighted by correlative studies suggesting that phosphorylation may be involved in modulating either steroid binding, DNA binding or transactivation (Bagchi et al. 1992; Takimoto et al. 1992).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ali S, Metzger D, Bornert JM, Chambon P (1993) Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J 12: 1153–1160
Aronica SM, Katzenellenbogen BS (1993) Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol 7: 743–752
Bagchi MK, Tsai S-Y, Tsai M-J, O’Malley BW (1992) Ligand and DNA-dependent phosphorylation of human progesterone receptor in vitro. Proc Natl Acad Sci USA 89: 2664–2668
Bunone G, Briand P-A, Miksicek RJ, Picard D (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15: 2174–2183
Denner LA, Weigel NL, Maxwell BL, Schrader WT, O’Malley BW (1990) Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250: 1740–1743
Ekena K, Weis KE, Katzenellenbogen JA, Katzenellenbogen BS (1996) Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding. J Biol Chem 271: 20053–20059
El-Tanani MK, Green CD (1997) Two separate mechanisms for ligand-inde- pendent activation of the estrogen receptor. Mol Endocrinol 11: 928–937
Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240: 889–895
Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231: 1150–1154
Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA (1993) Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7: 992–998
Ignar-Trowbridge DM, Pimentel M, Teng CT, Korach KS, McLachlan JA (1995) Cross talk between peptide growth factor and estrogen receptor signaling systems. Environ Health Perspect 103: 35–38
Ignar-Trowbridge DM, Pimentej M, Parker MG, McLachlan JA, Korach KS (1996) Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 137: 1735–1744
Jackson DM, Westlind-Danielsson A (1994) Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64: 291–370
Kabebian JW, Calne DB (1979) multiple receptors for dopamine. Nature 277: 93–96
Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491–1494
Kumar V, Green S, Stack G, Berry M, Jin J-R, Chambon P (1987) Functional domains of the human estrogen receptor. Cell 51: 941–951
Le Goff P, Montano MR, Schodin DJ, Katzenellenbogen BS (1994) Phosphorylation of the human estrogen receptor — identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem 269: 4458–4466
Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A (1994) Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-Er3. Mol Endocrinol 8: 910–918
Miner JN, Yamamoto KR (1991) Regulatory crosstalk at composite response elements. Trends Biochem Sci 16: 423–426
Neff S, Sadowski C, Miksicek RJ (1994) Mutational analysis of cysteine residues within the hormone-binding domain of the human estrogen receptor identifies mutants that are defective in both DNA-binding and subcellular distribution. Mol Endocrinol 8: 1215–1223
Newton CJ, Buric R, Trapp T, Brockmeier S, Pagotto U, Stalla GK (1994) The unliganded estrogen receptor ( ER) transduces growth factor signals. J Steroid Biochem Mol Biol 48: 481–486
Patrone C, Ma ZQ, Pollio G, Agrati P, Parker MG, Maggi A (1996) Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Mol Endocrinol 10: 499–507
Picard D, Bunone G, Liu JW, Donzé O (1997) Steroid-independent activation of steroid receptors in mammalian and yeast cells and in breast cancer. Biochem Soc Trans 25: 597–602
Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX, Slamon DJ (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10: 2435–2446
Power RF, Mani SK, Codina J, Conneely OM, O’Malley BW (1991) Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254: 1636–1639
Saatcioglu F, Claret FX, Karin M (1994) Negative transcriptional regulation by nuclear receptors. Semin Cancer Biol 5: 347–359
Smith CL, Conneely OM, O’Malley BW (1993) Modulation of the ligand-independent activation of the human estrogen receptor by hormone and anti-hormone. Proc Natl Acad Sci USA 90: 6120–6124
Takimoto GS, Tasset DM, Eppert AC, Horwitz KB (1992) Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299. Proc Natl Acad Sci USA 89: 3050–3054
Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P (1989) The cloned human estrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8: 1981–1986
Tsai M-J, O’Malley BW (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63: 451–486
Webster NJG, Green S, Jin JR, Chambon P (1988) The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54: 199–207
Weigel NL, Zhang Y (1997) Ligand-independent activation of steroid hormone receptors. J Mol Med (in press)
Weis KE, Ekena K, Thomas JA, Lazennec G, Katzenellenbogen BS (1996) Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol Endocrinol 10: 1388–1398
White R, Sjoberg M, Kalkhoven E, Parker MG (1997) Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J 16: 1427–1435
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Donzé, O., Picard, D. (1998). Ligand-Independent Activation of the Estrogen Receptor: Activation by Epidermal Growth Factor and Dopamine. In: Gronemeyer, H., Fuhrmann, U., Parczyk, K. (eds) Molecular Basis of Sex Hormone Receptor Function. Ernst Schering Research Foundation Workshop, vol 24. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03689-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-03689-1_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-03691-4
Online ISBN: 978-3-662-03689-1
eBook Packages: Springer Book Archive